封面
市場調查報告書
商品編碼
1855931

2025年全球新生兒即時檢測市場報告

Neonatal Point Of Care Testing Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來,新生兒即時檢測市場發展迅速,預計從2024年的11.6億美元成長到2025年的13.2億美元,複合年成長率達14.6%。這一成長主要受以下因素驅動:新生兒疾病發病率上升、對快速診斷結果的需求增加、人們對新生兒健康風險的認知不斷提高、早產率上升以及醫院擴大採用床邊檢測。

預計未來幾年新生兒即時檢測市場將快速成長,到2029年市場規模將達到22.7億美元,複合年成長率(CAGR)為14.4%。預測期內的成長預計將受到以下因素的推動:對個人化新生兒護理的需求不斷成長、可攜式檢測設備的普及率不斷提高、對早期疾病檢測的偏好日益增強、對降低新生兒死亡率的關注度不斷提高,以及對先進診斷工具的投資不斷增加。預測期內的主要趨勢包括:生物感測器技術的進步、基於微流體技術的診斷平台的創新、多重檢測研發的增加、無線新生兒監護系統的開發以及照護現場分子檢測技術的創新。

預計對遠端患者監護日益成長的需求將推動新生兒即時檢測(POC​​)市場的擴張。遠端患者監護利用數位技術連接患者與醫療專業人員,無需患者親自到場即可獲得醫療保健服務。這種需求源自於對及時便捷醫療服務的需求,尤其是在醫療基礎設施有限的偏遠和低度開發地區。新生兒即時檢測在遠距監護中發揮關鍵作用,它可在床邊提供即時診斷結果,使醫護人員能夠快速識別和處理新生兒的危重健康狀況,而無需依賴中心檢查室。例如,根據美國醫療科技公司Rock Health在2023年2月進行的一項調查,76%的55歲及以上受訪者曾使用過遠端醫療,80%的受訪者在其一生中的某個階段接受遠端醫療醫療服務,高於2021年的72%。因此,對遠端患者監護日益成長的需求正在推動新生兒即時檢測市場的成長。

新生兒即時檢測(POC​​)市場的主要企業正在建立策略聯盟,以擴大診斷服務的覆蓋範圍並改善新生兒早期醫療保健。策略合作是指不同組織之間為了實現通用目標而建立的夥伴關係,這些組織匯集了各自的資源和專業知識。例如,2025年1月,總部位於荷蘭的樣本和檢測技術供應商QIAGEN與總部位於英國的基因組醫學夥伴關係Genomics England建立了合作關係。此次合作將支持「世代研究」(Generation Study)的推出,計劃旨在對英國10萬名新生兒的基因組進行定序,並識別200多種可治療的遺傳疾病。 QIAGEN將為POC定序測試中評估的基因提供具有臨床意義的遺傳變異數據,從而加快分析和結果報告的速度。該研究計畫於2024年10月正式啟動,預計將對英國每年約3,000名新生兒所患的疾病的早期發現和治療產生正面影響。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場:宏觀經濟情景,包括利率、通貨膨脹、地緣政治、貿易戰和關稅,以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球新生兒即時檢測:PESTEL 分析(政治、社會、技術、環境、法律因素、促進因素與限制因素)
  • 終端用戶產業分析
  • 全球新生兒即時偵測市場:成長率分析
  • 全球新生兒即時檢測市場表現:規模與成長,2019-2024年
  • 全球新生兒即時檢測市場預測:規模與成長,2024-2029年,2034年
  • 全球新生兒即時檢測:潛在市場規模 (TAM)

第6章 市場細分

  • 全球新生兒即時檢測市場依產品、效能及預測分類,2019-2024年、2024-2029年、2034年
  • 裝置
  • 偵測
  • 全球新生兒即時檢測市場依檢測類型、效能及預測分類,2019-2024年、2024-2029年、2034年
  • 新生兒膽紅素檢測
  • 新生兒代謝篩檢
  • 血糖值檢測
  • 傳染病篩檢
  • 電解質測試
  • 其他測試類型
  • 全球新生兒即時檢測市場(按最終用戶、性能和預測分類,2019-2024年、2024-2029年、2034年)
  • 醫院
  • 診斷中心
  • 婦產科和專科診所
  • 其他最終用戶
  • 全球新生兒即時檢測市場:按設備、類型、性能和預測進行細分,2019-2024年、2024-2029年、2034年
  • 血氣分析儀
  • 膽紅素儀
  • 血糖儀
  • 血液分析儀
  • 多專案監視器
  • 全球新生兒即時檢測市場:按檢測方法、類型、性能和預測進行細分,2019-2024年、2024-2029年、2034年
  • 膽紅素測定
  • 葡萄糖測定
  • 感染疾病試驗
  • 血液學檢測
  • 心臟標記檢測
  • 電解質測定
  • 血氣分析

第7章 區域和國家分析

  • 全球新生兒即時檢測市場:區域表現及預測,2019-2024年、2024-2029年及2034年
  • 全球新生兒即時檢測市場:國家、績效及預測,2019-2024年、2024-2029年、2034年

第8章 亞太市場

第9章:中國市場

第10章 印度市場

第11章 日本市場

第12章:澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章:德國市場

第18章:法國市場

第19章:義大利市場

第20章:西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章:加拿大市場

第26章 南美洲市場

第27章:巴西市場

第28章 中東市場

第29章:非洲市場

第30章:競爭格局與公司概況

  • 新生兒即時偵測市場:競爭格局
  • 新生兒即時檢測市場:公司概況
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Konica Minolta Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章:其他領先和創新企業

  • Drager Ag Co. Kg
  • Bio-Rad Laboratories Inc.
  • Masimo Corporation
  • QIAGEN Inc.
  • Radiometer Ltd.
  • Contec Medical Systems Co. Ltd.
  • Owen Mumford Ltd.
  • Nova Biomedical
  • Heal Force Bio Meditech Holdings Ltd.
  • Edan Instruments Inc.
  • Trivitron Healthcare
  • Bistos Co. Ltd.
  • Bilimetrix SrI
  • GINEVRI srl
  • Hadleigh Health Technologies

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章:高潛力市場國家、細分市場與策略

  • 2029年新生兒即時檢測市場:提供新機會的國家
  • 2029年新生兒即時檢測市場:新興細分市場機會
  • 2029年新生兒即時檢測市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38583

Neonatal point-of-care testing is the practice of performing diagnostic evaluations near the location where newborns receive care. It provides immediate clinical information, enabling rapid and informed decision-making. This approach delivers timely and accurate results while reducing the delays and logistical challenges associated with traditional laboratory testing.

The primary products in neonatal point-of-care testing include instruments and assays. Instruments consist of portable analyzers, handheld readers, and bedside monitors used to assess newborn health directly in care settings. Test types include neonatal bilirubin testing, newborn metabolic screening, blood glucose testing, infectious disease screening, electrolyte testing, and others. Key end-users include hospitals, diagnostic centers, maternity and specialty clinics, and additional healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The neonatal point of care testing market research report is one of a series of new reports from The Business Research Company that provides neonatal point of care testing market statistics, including neonatal point of care testing industry global market size, regional shares, competitors with a neonatal point of care testing market share, detailed neonatal point of care testing market segments, market trends and opportunities, and any further data you may need to thrive in the neonatal point of care testing industry. This neonatal point of care testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neonatal point of care testing market size has grown rapidly in recent years. It will grow from $1.16 billion in 2024 to $1.32 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. Growth in the historic period was driven by the rising incidence of neonatal disorders, increasing demand for rapid diagnostic results, greater awareness of neonatal health risks, higher prevalence of preterm births, and growing hospital adoption of bedside testing.

The neonatal point of care testing market size is expected to see rapid growth in the next few years. It will grow to $2.27 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. Growth in the forecast period is expected to be supported by rising demand for personalized neonatal care, increased adoption of portable testing devices, growing preference for early disease detection, heightened focus on reducing neonatal mortality rates, and greater investment in advanced diagnostic tools. Key trends anticipated for the forecast period include advancements in biosensor technology, innovation in microfluidic-based diagnostic platforms, increased research and development for multiplex assays, development of wireless neonatal monitoring systems, and innovation in point-of-care molecular testing.

The growing demand for remote patient monitoring is anticipated to support the expansion of the neonatal point of care testing market. Remote patient monitoring refers to the use of digital technology to provide healthcare services by connecting patients with medical professionals without requiring in-person visits. This demand is rising due to the need for timely, accessible care, particularly in remote and underserved areas where medical infrastructure may be limited. Neonatal point of care testing plays a key role in remote monitoring by delivering immediate diagnostic results at the bedside, allowing healthcare providers to rapidly identify and address critical health conditions in newborns without depending on central laboratories. For example, in February 2023, a survey conducted by Rock Health, a health technology company based in the United States, showed that seventy-six percent of respondents over the age of fifty-five had used telemedicine, while eighty percent of all participants had accessed healthcare through telemedicine at some point in their lives, up from seventy-two percent in 2021. Therefore, the rising demand for remote patient monitoring is driving growth in the neonatal point of care testing market.

Leading companies in the neonatal point of care testing market are forming strategic collaborations to expand access to diagnostics and improve early healthcare for newborns. Strategic collaborations involve partnerships between organizations that combine their resources and expertise to reach shared objectives. For example, in January 2025, QIAGEN, a provider of sample and assay technologies based in the Netherlands, entered a partnership with Genomics England, a genomic medicine organization located in the United Kingdom. This collaboration supported the launch of the Generation Study, a project aimed at sequencing the genomes of one hundred thousand newborns in England to identify more than two hundred treatable genetic conditions. QIAGEN is contributing clinically relevant genetic variant data for the genes assessed in the point of care sequencing test, enabling faster analysis and reporting of results. The study officially began in October 2024 and is expected to impact the early detection and treatment of conditions affecting approximately three thousand newborns each year in the United Kingdom.

In March 2025, LaCAR MDx Technologies, a biotechnology company based in Belgium, acquired the newborn screening division of Baebies Incorporated for an undisclosed amount. This acquisition expands LaCAR's portfolio by increasing the range of neonatal diagnostic solutions it can offer and supports the company's growth in the United States market. Baebies Incorporated is a company based in the United States that specializes in neonatal point of care testing.

Major players in the neonatal point of care testing market are Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Konica Minolta Inc., Drager Ag Co. Kg, Bio-Rad Laboratories Inc., Masimo Corporation, QIAGEN Inc., Radiometer Ltd., Contec Medical Systems Co. Ltd., Owen Mumford Ltd., Nova Biomedical, Heal Force Bio Meditech Holdings Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix S.r.I, GINEVRI srl, Hadleigh Health Technologies.

North America was the largest region in the neonatal point of care testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neonatal point of care testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neonatal point of care testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neonatal point of care testing market consists of revenues earned by entities by providing services such as rapid diagnostic screening, blood gas and electrolyte analysis, glucose level monitoring, and sepsis detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The neonatal point of care testing market also includes sales of portable diagnostic analyzers, oxygen saturation monitors, hematology analyzers, and lactate analyzers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neonatal Point Of Care Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neonatal point of care testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neonatal point of care testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neonatal point of care testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Instruments; Assay
  • 2) By Test Type: Neonatal Bilirubin Testing; Newborn Metabolic Screening; Blood Glucose Testing; Infectious Disease Screening; Electrolyte Testing; Other Test Types
  • 3) By End-Users: Hospitals; Diagnostic Centers; Maternity And Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) By Instruments: Blood Gas Analyzers; Bilirubinometers; Glucose Meters; Hematology Analyzers; Multiparameter Monitors
  • 2) By Assay: Bilirubin Assays; Glucose Assays; Infectious Disease Assays; Hematology Assays; Cardiac Marker Assays; Electrolyte Assays; Blood Gas Assays
  • Companies Mentioned: Abbott Laboratories; Siemens Healthineers AG; Koninklijke Philips N.V.; GE Healthcare Technologies Inc.; Konica Minolta Inc.; Drager Ag Co. Kg; Bio-Rad Laboratories Inc.; Masimo Corporation; QIAGEN Inc.; Radiometer Ltd.; Contec Medical Systems Co. Ltd.; Owen Mumford Ltd.; Nova Biomedical; Heal Force Bio Meditech Holdings Ltd.; Edan Instruments Inc.; Trivitron Healthcare; Bistos Co. Ltd.; Bilimetrix S.r.I; GINEVRI srl; Hadleigh Health Technologies.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neonatal Point Of Care Testing Market Characteristics

3. Neonatal Point Of Care Testing Market Trends And Strategies

4. Neonatal Point Of Care Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Neonatal Point Of Care Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Neonatal Point Of Care Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Neonatal Point Of Care Testing Market Growth Rate Analysis
  • 5.4. Global Neonatal Point Of Care Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Neonatal Point Of Care Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Neonatal Point Of Care Testing Total Addressable Market (TAM)

6. Neonatal Point Of Care Testing Market Segmentation

  • 6.1. Global Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Assay
  • 6.2. Global Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Neonatal Bilirubin Testing
  • Newborn Metabolic Screening
  • Blood Glucose Testing
  • Infectious Disease Screening
  • Electrolyte Testing
  • Other Test Types
  • 6.3. Global Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Maternity And Speciality Clinics
  • Other End-Users
  • 6.4. Global Neonatal Point Of Care Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Gas Analyzers
  • Bilirubinometers
  • Glucose Meters
  • Hematology Analyzers
  • Multiparameter Monitors
  • 6.5. Global Neonatal Point Of Care Testing Market, Sub-Segmentation Of Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bilirubin Assays
  • Glucose Assays
  • Infectious Disease Assays
  • Hematology Assays
  • Cardiac Marker Assays
  • Electrolyte Assays
  • Blood Gas Assays

7. Neonatal Point Of Care Testing Market Regional And Country Analysis

  • 7.1. Global Neonatal Point Of Care Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Neonatal Point Of Care Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neonatal Point Of Care Testing Market

  • 8.1. Asia-Pacific Neonatal Point Of Care Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neonatal Point Of Care Testing Market

  • 9.1. China Neonatal Point Of Care Testing Market Overview
  • 9.2. China Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neonatal Point Of Care Testing Market

  • 10.1. India Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neonatal Point Of Care Testing Market

  • 11.1. Japan Neonatal Point Of Care Testing Market Overview
  • 11.2. Japan Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neonatal Point Of Care Testing Market

  • 12.1. Australia Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neonatal Point Of Care Testing Market

  • 13.1. Indonesia Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neonatal Point Of Care Testing Market

  • 14.1. South Korea Neonatal Point Of Care Testing Market Overview
  • 14.2. South Korea Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neonatal Point Of Care Testing Market

  • 15.1. Western Europe Neonatal Point Of Care Testing Market Overview
  • 15.2. Western Europe Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neonatal Point Of Care Testing Market

  • 16.1. UK Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neonatal Point Of Care Testing Market

  • 17.1. Germany Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neonatal Point Of Care Testing Market

  • 18.1. France Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neonatal Point Of Care Testing Market

  • 19.1. Italy Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neonatal Point Of Care Testing Market

  • 20.1. Spain Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neonatal Point Of Care Testing Market

  • 21.1. Eastern Europe Neonatal Point Of Care Testing Market Overview
  • 21.2. Eastern Europe Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neonatal Point Of Care Testing Market

  • 22.1. Russia Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neonatal Point Of Care Testing Market

  • 23.1. North America Neonatal Point Of Care Testing Market Overview
  • 23.2. North America Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neonatal Point Of Care Testing Market

  • 24.1. USA Neonatal Point Of Care Testing Market Overview
  • 24.2. USA Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neonatal Point Of Care Testing Market

  • 25.1. Canada Neonatal Point Of Care Testing Market Overview
  • 25.2. Canada Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neonatal Point Of Care Testing Market

  • 26.1. South America Neonatal Point Of Care Testing Market Overview
  • 26.2. South America Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neonatal Point Of Care Testing Market

  • 27.1. Brazil Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neonatal Point Of Care Testing Market

  • 28.1. Middle East Neonatal Point Of Care Testing Market Overview
  • 28.2. Middle East Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neonatal Point Of Care Testing Market

  • 29.1. Africa Neonatal Point Of Care Testing Market Overview
  • 29.2. Africa Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neonatal Point Of Care Testing Market Competitive Landscape And Company Profiles

  • 30.1. Neonatal Point Of Care Testing Market Competitive Landscape
  • 30.2. Neonatal Point Of Care Testing Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Konica Minolta Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Neonatal Point Of Care Testing Market Other Major And Innovative Companies

  • 31.1. Drager Ag Co. Kg
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. Masimo Corporation
  • 31.4. QIAGEN Inc.
  • 31.5. Radiometer Ltd.
  • 31.6. Contec Medical Systems Co. Ltd.
  • 31.7. Owen Mumford Ltd.
  • 31.8. Nova Biomedical
  • 31.9. Heal Force Bio Meditech Holdings Ltd.
  • 31.10. Edan Instruments Inc.
  • 31.11. Trivitron Healthcare
  • 31.12. Bistos Co. Ltd.
  • 31.13. Bilimetrix S.r.I
  • 31.14. GINEVRI srl
  • 31.15. Hadleigh Health Technologies

32. Global Neonatal Point Of Care Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neonatal Point Of Care Testing Market

34. Recent Developments In The Neonatal Point Of Care Testing Market

35. Neonatal Point Of Care Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Neonatal Point Of Care Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Neonatal Point Of Care Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Neonatal Point Of Care Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer